
Oropep 4.5 Injection
Marketer
Rishab Healthcare pvt. Ltd.
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Oropep 4.5 Injection
Oropep 4.5 Injection combines two antibiotics to combat diverse bacterial infections by eliminating microorganisms. Administered solely by healthcare professionals, self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on illness severity; adherence to the prescribed regimen is crucial. Common side effects may include nausea, vomiting, diarrhea, and rash, alongside potential injection site reactions such as pain, swelling, or redness. Persistent or worsening side effects necessitate immediate medical consultation. Prior to treatment, disclose any antibiotic allergies, kidney, or liver conditions to your doctor, who may adjust the dosage or recommend an alternative. While generally safe under medical guidance, its use during pregnancy and breastfeeding should be overseen by a physician.
Primary Ingredients of Oropep 4.5 Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Oropep 4.5 Injection
Infections caused by bacteria
Major Benefits of Oropep 4.5 Injection:
Administering this medication will be handled by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Oropep 4.5 Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Oropep 4.5 Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Oropep 4.5 Injection works:
Oropep 4.5 Injection combines piperacillin, an antibiotic, with tazobactam, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam counteracts bacterial resistance mechanisms, thereby boosting piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no adverse reactions reported from concurrent use of Oropep 4.5 Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The administration of Oropep 4.5 Injection during pregnancy is typically deemed safe. Preclinical trials in animals have revealed minimal or no harmful consequences for fetal development; nevertheless, research involving human subjects is scarce.
Breast feedingSAFE IF PRESCRIBED
Administering Oropep 4.5 Injection while breastfeeding is considered safe. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
Oropep 4.5 Injection's effect on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should receive Oropep 4.5 Injection with close monitoring. Dosage modification for Oropep 4.5 Injection might be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
Oropep 4.5 Injection appears safe for use in individuals with hepatic impairment. Existing evidence indicates dose modification may not be necessary. Physician consultation is recommended.
What if you forget to take Oropep 4.5 Injection :
Omitting a scheduled Oropep 4.5 Injection dose requires contacting your physician.
Facts to Know About Oropep 4.5 Injection
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Antimicrobial Agents |
